SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Guggenheim Maintains Merck at Buy, Raises Price Target to $171

Guggenheim raised its price target from $170 to $171. The new target implies 16.9% upside from Merck's Oct. 29 close of $146.33.

MRK

Related stories